AZT.OL实时信号 | 通过Getagraph.com最大化利润

购买 3149 min ago

@ Kr.25.40

发出时间: 31 May 2024 @ 21:20

回报率: 0.79%

上一信号: May 31 - 20:03

上一信号: 出售

回报率: 0.99 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 22:27):
Our systems believe the stock currently is overvalued by 0.54% compare to its pairs and should correct downwards.

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing...

Stats
今日成交量	778 532
平均成交量	59 348.00
市值	1.30B
EPS	Kr.0 ( 2024-05-07 )
下一个收益日期	( Kr.0.0900 ) 2024-08-21
Last Dividend	Kr.0 ( N/A )
Next Dividend	Kr.0 ( N/A )
P/E	75.29
ATR14	Kr.1.747 (6.84%)

相关性 (AI algo v.1.1b): Overvalued: -0.54% Kr.25.41 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.70 (moderate)

短: 1.00 (very strong)

Signal:(82) Expect same movement, but be aware

Arcticzymes Technologies 相关性

10 最正相关
IOX.OL	0.916
ELIMP.OL	0.878
PLT.OL	0.866
PRS.OL	0.865
ARGEO.OL	0.856
ACC.OL	0.834
HBC.OL	0.834
HEX.OL	0.815

10 最负相关
PROT.OL	-0.907
SVEG.OL	-0.894
AGLX.OL	-0.873
BRG.OL	-0.867
KOG.OL	-0.86
2020.OL	-0.855
SOGN.OL	-0.844
GOGL.OL	-0.844
SNI.OL	-0.839
GOD.OL	-0.83

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Arcticzymes Technologies 相关性 - 货币/商品

-0.02
( neutral )

0.54
( weak )

0.00
( neutral )

0.59
( weak )

-0.10
( neutral )

0.43
( neutral )

Arcticzymes Technologies 财务报表

Annual	2023
营收:	Kr.118.94M
毛利润:	Kr.39.57M (33.27 %)
EPS:	Kr.0.380

FY	2023
营收:	Kr.118.94M
毛利润:	Kr.39.57M (33.27 %)
EPS:	Kr.0.380

FY	2022
营收:	Kr.136.97M
毛利润:	Kr.131.79M (96.22 %)
EPS:	Kr.0.650

FY	2021
营收:	Kr.127.97M
毛利润:	Kr.124.09M (96.96 %)
EPS:	Kr.0.940

Financial Reports:

No articles found.

Arcticzymes Technologies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Arcticzymes Technologies

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway.